Revista médica de Chile
-
Revista médica de Chile · Sep 2024
Randomized Controlled Trial[Health Literacy and Metabolic Control in Individuals Diagnosed with Type 2 Diabetes Mellitus: A Cluster Randomized Clinical Trial].
People with type 2 diabetes mellitus (DM2) experience difficulties in self-management. One of the variables involved is the low level of health literacy (HL) which corresponds to the degree to which people access, understand, evaluate and use information to engage with health demands in different contexts, in order to promote and maintain good health. ⋯ An intervention that considers LS adapted to the Latin American sociocultural context with a combination of group and individual strategies can generate a difference in HBA1c.
-
Revista médica de Chile · Oct 2022
Randomized Controlled Trial[Suturing basic procedural skills training for medical students during COVID-19 pandemic].
The adoption of sanitary measures due to the SARS-CoV-2 pandemic hampered teaching and learning methods in medicine. ⋯ Despite all the limitations of the pandemic context, we achieved a significant improvement after the intervention and a very good perception by the students.
-
Revista médica de Chile · Jun 2022
Randomized Controlled Trial[Training of health care workers on the Chronic Care Model].
The Chronic Care Model promotes the link between informed, activated patients with proactive and prepared health care teams. ⋯ This intervention improved the evaluation of chronic disease care in the intervention group.
-
Revista médica de Chile · Nov 2021
Randomized Controlled Trial[Simulation of tracheal intubation for medical students. The effects of anticipatory study].
Clinical simulation allows the acquisition of procedural skills among medical students. The anticipatory study of these skills may improve the efficiency of simulation sessions. ⋯ Study guides improve practice effectiveness. Our results indicate that the best results are obtained by simulation accompanied with immediate directed feedback and opportunities to repeat the procedures, independent of the type of anticipatory study.
-
Revista médica de Chile · Jan 2021
Randomized Controlled Trial[The impact on sample sizes of studies if the significance level is changed from an α of 0.05 to 0.005].
The statistical significance α = 0.05 is the cut-off point used to decide whether a hypothesis is statistically significant. When p-value is less than 0.05, we reject the null hypothesis. Although this criterion has been used for almost a century to generate new knowledge, there is currently an international discussion about the need to decrease the significance to α = 0.005. ⋯ Considering the sample size implications, the change in the level of significance would have important effects on the Chilean science. The cost of a randomized clinical trial could increase by at least 27% to 32%. This increase could be similar for cross-sectional studies. With an investment of less than 0.4% of gross domestic product in science and technology, national scientific research would become more expensive, distributing the few available resources among fewer projects. This effect should be considered in any discussion about national budget for science and technology.